 This open-label, randomized study is being conducted to determine whether a dose of 400 mcg of buccal misoprostol i.e., in the cheek taken 24 hours following administration of mifepristone 200 mg is as effective and acceptable at inducing an abortion compared with misoprostol taken sublingually under the tongue. Women presenting for voluntary termination of intrauterine pregnancy with gestational ages of 63 days will be offered the option of participating in the study. 